Identification of ASF1B As a Prognostic Marker for Liver Cancer by Meta-analysis and Its Immune Value Revealed by a Comprehensive Pan-cancer Analysis of 33 Human Cancers

Overview

Journal Prz Gastroenterol

Publisher Termedia

Specialty Gastroenterology

Date 2023 Nov 8

PMID 37937108

Authors

Yiyang Chen

Wanbang Zhou

Yiju Gong

Xi Ou

Affiliations

Soon will be listed here.

Abstract

Introduction: As one of the most common malignant tumours, liver cancer is difficult to detect in the early stage, with strong metastasis and poor prognosis. Anti-silencing function protein 1 was originally discovered in yeast as a histone H3-H4 chaperone, and studies have shown that ASF1B may be a target for inhibiting the growth of hepatocellular carcinoma cells.

Aim: To evaluate the diagnostic and prognostic significance of ASF1B expression in human LIHC on the basis of TCGA data.

Material And Methods: A meta-analysis revealed that high ASF1B expression was strongly associated with better overall survival. A comprehensive pan-cancer analysis of 33 human cancers revealed the immunotherapeutic value of ASF1B.

Results: In this study, we observed a significant upregulation of ASF1B expression in LIHC samples compared to non-cancer samples. Clinical analysis showed that high expression of ASF1B was associated with age, tumour status, and clinical stage. Survival analysis showed that patients with high ASF1B expression had worse overall survival and progression-free survival than patients with low ASF1B expression. The AUCs of the 1-year, 3-year, and 5-year survival-related ROC curves were 0.672, 0.590, and 0.591, respectively.

Conclusions: Our study shows that ASF1B may provide new ideas for the diagnosis and prognosis of liver cancer patients, as well as providing a new direction for the application of ASF1B in tumour immunotherapy.

Citing Articles

The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma.

Tian Y, Qiu S, Yang S, Jiang Y, Hu H, Yang C BMC Cancer. 2024; 24(1):1463.

PMID: 39609679 PMC: 11603849. DOI: 10.1186/s12885-024-13097-6.

References

Pettinelli P, Arendt B, Teterina A, McGilvray I, Comelli E, Fung S . Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease. PLoS One. 2018; 13(10):e0205747. PMC: 6209208. DOI: 10.1371/journal.pone.0205747. View

Shi X, Xu X, Shi N, Chen Y, Fu M . MicroRNA-520d-3p suppresses melanoma cells proliferation by inhibiting the anti-silencing function 1B histone chaperone. Bioengineered. 2021; 12(2):10703-10715. PMC: 8809954. DOI: 10.1080/21655979.2021.2001914. View

Garcia M, Meissburger B, Chan J, de Guia R, Mattijssen F, Roessler S . Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death. Adv Sci (Weinh). 2022; 9(29):e2104291. PMC: 9561781. DOI: 10.1002/advs.202104291. View

Paul P, Rabaglia M, Wang C, Stapleton D, Leng N, Kendziorski C . Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3. Cell Cycle. 2016; 15(23):3191-3202. PMC: 5176155. DOI: 10.1080/15384101.2016.1241914. View

Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

Jiangqiao Z, Tao Q, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z . Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma. Biochem Biophys Res Commun. 2019; 511(1):165-172. DOI: 10.1016/j.bbrc.2019.02.060. View

Meng T, Tong Z, Yang M, Zhang Y, Liu Y, Wang Z . Immune implication of FAM83D gene in hepatocellular carcinoma. Bioengineered. 2021; 12(1):3578-3592. PMC: 8806426. DOI: 10.1080/21655979.2021.1950260. View

Han G, Zhang X, Liu P, Yu Q, Li Z, Yu Q . Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer. Int J Oncol. 2018; 53(5):2056-2066. PMC: 6192734. DOI: 10.3892/ijo.2018.4526. View

Chan C, Chen C, Wu Lee Y, You L . DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss. Mol Cancer Res. 2018; 17(2):555-566. DOI: 10.1158/1541-7786.MCR-18-0551. View

10.

Chen F, Wang J, Wu Y, Gao Q, Zhang S . Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy. Front Oncol. 2022; 12:822449. PMC: 8851237. DOI: 10.3389/fonc.2022.822449. View

11.

Montes de Oca R, Gurard-Levin Z, Berger F, Rehman H, Martel E, Corpet A . The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma. Mol Oncol. 2014; 9(3):657-74. PMC: 5528705. DOI: 10.1016/j.molonc.2014.11.002. View

12.

Liu K, Zhao D, Wang D . LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2019; 11(1):11-18. PMC: 6961595. DOI: 10.1080/21655979.2019.1704535. View

13.

Xiao Q, Cheng Z, Kuang W, Wu H, Luo X, Wang R . Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma. Appl Bionics Biomech. 2022; 2022:8926221. PMC: 8816587. DOI: 10.1155/2022/8926221. View

14.

Papadopoulos P, Kafasi A, De Cuyper I, Barroca V, Lewandowski D, Kadri Z . Mild dyserythropoiesis and β-like globin gene expression imbalance due to the loss of histone chaperone ASF1B. Hum Genomics. 2020; 14(1):39. PMC: 7566067. DOI: 10.1186/s40246-020-00283-3. View

15.

Bao X, Chen L, Liu Y, Sheng H, Wang K, Luo Y . Treatment of Liver Cancer: Role of the Traditional Mongolian Medicine. Evid Based Complement Alternat Med. 2022; 2022:6535977. PMC: 8860509. DOI: 10.1155/2022/6535977. View

16.

Loyola A, Almouzni G . Histone chaperones, a supporting role in the limelight. Biochim Biophys Acta. 2004; 1677(1-3):3-11. DOI: 10.1016/j.bbaexp.2003.09.012. View

17.

Yin X, Wu T, Lan Y, Yang W . Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma. Biosci Rep. 2022; 42(2). PMC: 8821949. DOI: 10.1042/BSR20212304. View

18.

OSullivan R, Arnoult N, Lackner D, Oganesian L, Haggblom C, Corpet A . Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat Struct Mol Biol. 2014; 21(2):167-74. PMC: 3946341. DOI: 10.1038/nsmb.2754. View

19.

Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery R . Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions. World J Gastroenterol. 2022; 28(4):432-448. PMC: 8790553. DOI: 10.3748/wjg.v28.i4.432. View

20.

Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X . Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 2022; 39(12):110986. DOI: 10.1016/j.celrep.2022.110986. View